Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 22
Filter
1.
BMC Pediatr ; 19(1): 217, 2019 07 02.
Article in English | MEDLINE | ID: mdl-31266458

ABSTRACT

BACKGROUND: Payer-type (government-sponsored health coverage versus private health insurance) has been shown to influence a variety of cardiovascular disease outcomes in adults. However, it is unclear if the payer-type impacts the response to a lifestyle intervention in children with dyslipidemia. METHODS: We analyzed data prospectively collected from patients under the age of 25 years who were referred to a large regional preventive cardiology clinic from 2010 to 2016 in Massachusetts. We compared baseline high density lipoprotein cholesterol (HDL-C), triglycerides (TG), non-HDL-C, and low density lipoprotein cholesterol (LDL-C) by payer-type. Further, we analyzed the change in lipid values in response to a clinic-based multidisciplinary intervention over a nearly six-year period by payer-type with multi-variable adjusted linear regression models. We also tested for effect modifications by age, sex, race, and body mass index (BMI) category. RESULTS: Of the 1739 eligible patients (mean age 13 years, 52% female, 60% overweight and obese, 59% White), we found that patients with government-sponsored coverage (n = 354, 20%) presented to referral lipid clinic with lower HDL-C (- 3.5 mg/dL [1.0], p < 0.001) and higher natural log-transformed TG (+ 0.14 [0.04], p < 0.001) as compared to those with private insurance; however, the association was attenuated to the null after additionally adjusting for BMI category (- 1.1 [0.9], p = 0.13, and + 0.05 [0.04], p = 0.2 for HDL-C and natural log-transformed TG, respectively). We found no difference in baseline LDL-C between payer-types (+ 3.4 mg/dL [3.0], p = 0.3). However, longitudinally, we found patients with private insurance and a self-reported race of White to have a clinically meaningful additional improvement in LDL-C, decreasing 12.8 (5.5) mg/dL (p = 0.02) between baseline and first follow-up, as compared to White patients with government-sponsored health coverage, after adjusting for age, sex, time between visits, and baseline LDL-C. CONCLUSIONS: Our results suggest that youth with government-sponsored coverage are referred with poorer lipid profiles than those with private insurance, although this is largely explained by higher rates of overweight and obesity in the government-sponsored health coverage group. White patients with private insurance had substantially better improvement in LDL-C longitudinally, suggesting that higher socioeconomic status facilitates improvement in LDL-C, but is less beneficial for HDL-C and triglyceride levels.


Subject(s)
Dyslipidemias/blood , Insurance, Health, Reimbursement/classification , Life Style , Lipids/blood , Pediatric Obesity/blood , Triglycerides/blood , Adolescent , Age Factors , Body Mass Index , Child , Cholesterol, HDL/blood , Cholesterol, LDL/blood , Dyslipidemias/ethnology , Female , Financing, Government , Humans , Male , Massachusetts/epidemiology , Pediatric Obesity/epidemiology , Pediatric Obesity/ethnology , Private Sector , Prospective Studies , Regression Analysis , Sex Factors , White People , Young Adult
2.
Unfallchirurg ; 117(1): 54-9, 2014 Jan.
Article in German | MEDLINE | ID: mdl-23069863

ABSTRACT

BACKGROUND: The treatment of osteoporotic vertebral fractures by means of kyphoplasty is an accepted and safe procedure. AIM: In Germany the reimbursement for kyphoplasty and vertebroplasty differs greatly. The growing diversity of suppliers and systems makes a comparison possible and necessary. Besides the illustration of kyphoplasty in the German diagnosis-related group (G-DRG) system and the amendments for 2012 we analyzed the procedures and associated costs. METHOD: Using the example of two manufacturers and different system approaches, both of which can be charged as kyphoplasty, we try to point out the importance of selecting exact comparison parameters. In particular material and treatment costs are compared for both methods.


Subject(s)
Health Care Costs/statistics & numerical data , Insurance, Health, Reimbursement/economics , Kyphoplasty/economics , Osteoporotic Fractures/economics , Osteoporotic Fractures/therapy , Spinal Fractures/economics , Spinal Fractures/therapy , Aged , Aged, 80 and over , Diagnosis-Related Groups/economics , Female , Germany/epidemiology , Health Care Costs/classification , Humans , Insurance, Health, Reimbursement/classification , Kyphoplasty/classification , Male , Middle Aged , Osteoporotic Fractures/epidemiology , Prevalence , Spinal Fractures/epidemiology
6.
Artif Intell Med ; 51(1): 27-41, 2011 Jan.
Article in English | MEDLINE | ID: mdl-21129939

ABSTRACT

OBJECTIVE: With the non-stop increases in medical treatment fees, the economic survival of a hospital in Taiwan relies on the reimbursements received from the Bureau of National Health Insurance, which in turn depend on the accuracy and completeness of the content of the discharge summaries as well as the correctness of their International Classification of Diseases (ICD) codes. The purpose of this research is to enforce the entire disease classification framework by supporting disease classification specialists in the coding process. METHODOLOGY: This study developed an ICD code advisory system (ICD-AS) that performed knowledge discovery from discharge summaries and suggested ICD codes. Natural language processing and information retrieval techniques based on Zipf's Law were applied to process the content of discharge summaries, and fuzzy formal concept analysis was used to analyze and represent the relationships between the medical terms identified by MeSH. In addition, a certainty factor used as reference during the coding process was calculated to account for uncertainty and strengthen the credibility of the outcome. RESULTS: Two sets of 360 and 2579 textual discharge summaries of patients suffering from cerebrovascular disease was processed to build up ICD-AS and to evaluate the prediction performance. A number of experiments were conducted to investigate the impact of system parameters on accuracy and compare the proposed model to traditional classification techniques including linear-kernel support vector machines. The comparison results showed that the proposed system achieves the better overall performance in terms of several measures. In addition, some useful implication rules were obtained, which improve comprehension of the field of cerebrovascular disease and give insights to the relationships between relevant medical terms. CONCLUSION: Our system contributes valuable guidance to disease classification specialists in the process of coding discharge summaries, which consequently brings benefits in aspects of patient, hospital, and healthcare system.


Subject(s)
Artificial Intelligence , Cerebrovascular Disorders/classification , Data Mining , Hospital Costs/classification , Hospital Information Systems , Insurance, Health, Reimbursement/classification , International Classification of Diseases , Patient Discharge , Algorithms , Cerebrovascular Disorders/diagnosis , Cerebrovascular Disorders/economics , Cerebrovascular Disorders/therapy , Fuzzy Logic , Humans , Medical Subject Headings , National Health Programs , Natural Language Processing , Patient Discharge/economics , Taiwan
7.
Health Serv Res ; 44(6): 2022-39, 2009 Dec.
Article in English | MEDLINE | ID: mdl-19732167

ABSTRACT

OBJECTIVE: To quantify the variation in emergency department (ED) wait times by patient race/ethnicity and payment source, and to divide the overall association into between- and within-hospital components. DATA SOURCE: 2005 and 2006 National Hospital Ambulatory Medical Care Surveys. STUDY DESIGN: Linear regression was used to analyze the independent associations between race/ethnicity, payment source, and ED wait times in a pooled cross-sectional design. A hybrid fixed effects specification was used to measure the between- and within-hospital components. DATA EXTRACTION METHODS: Data were limited to children under 16 years presenting at EDs. PRINCIPAL RESULTS: Unadjusted and adjusted ED wait times were significantly longer for non-Hispanic black and Hispanic children than for non-Hispanic white children. Children in EDs with higher shares of non-Hispanic black and Hispanic children waited longer. Moreover, Hispanic children waited 10.4 percent longer than non-Hispanic white children when treated at the same hospital. ED wait times for children did not vary significantly by payment source. CONCLUSIONS: There are sizable racial/ethnic differences in children's ED wait times that can be attributed to both the racial/ethnic mix of children in EDs and to differential treatment by race/ethnicity inside the ED.


Subject(s)
Efficiency, Organizational , Emergency Service, Hospital , Ethnicity , Insurance, Health, Reimbursement/classification , Racial Groups , Waiting Lists , Adolescent , Child , Child, Preschool , Cross-Sectional Studies , Female , Health Care Surveys , Healthcare Disparities , Humans , Linear Models , Male , Time Factors , United States
8.
Cardiovasc Drugs Ther ; 22(6): 487-94, 2008 Dec.
Article in English | MEDLINE | ID: mdl-18792772

ABSTRACT

PURPOSE: This study aims to quantify costs of atherosclerotic cardiovascular diseases in Belgium in 2004. METHODS: Costs were estimated using data on prevalence, healthcare resource utilization and unit costs. Healthcare costs included expenditure on ambulatory care, hospital inpatient care, emergency care, and medications. Costs of prevention campaigns and costs of productivity loss were also included. RESULTS: Costs amounted to 3.5 billion euros in Belgium in 2004. Total costs consisted of 80 million euros related to prevention and screening, 1.3 billion euros related to pre-clinical disease, and 2.2 billion euros related to established disease. These costs were incurred by the Belgian third-party payer (58% of costs), patients (10%) and third parties (i.e. employers and supplementary health insurance) (32%). CONCLUSIONS: Atherosclerotic cardiovascular diseases impose a significant economic burden on Belgian society.


Subject(s)
Atherosclerosis/economics , Cost of Illness , Atherosclerosis/diagnosis , Atherosclerosis/drug therapy , Atherosclerosis/prevention & control , Belgium , Cerebrovascular Disorders/diagnosis , Cerebrovascular Disorders/economics , Cerebrovascular Disorders/prevention & control , Coronary Artery Disease/diagnosis , Coronary Artery Disease/economics , Coronary Artery Disease/prevention & control , Cost-Benefit Analysis , Female , Financing, Personal/economics , Financing, Personal/statistics & numerical data , Health Care Costs , Humans , Insurance, Health, Reimbursement/classification , Insurance, Health, Reimbursement/economics , Insurance, Health, Reimbursement/statistics & numerical data , Male , Peripheral Vascular Diseases/diagnosis , Peripheral Vascular Diseases/economics , Peripheral Vascular Diseases/prevention & control , Prevalence , Preventive Health Services/economics , Preventive Health Services/statistics & numerical data , Sensitivity and Specificity
9.
Gen Hosp Psychiatry ; 30(1): 73-6, 2008.
Article in English | MEDLINE | ID: mdl-18164944

ABSTRACT

OBJECTIVE: This study aimed (a) to discern the distribution by primary payer (public vs. private) of U.S. patients aged 5-18 years who were hospitalized with a primary diagnosis of depression and (b) to discern the mean hospital length of stay and mean charge per day by payer type. METHODS: The 2003 Healthcare Cost and Utilization Project Kids' Inpatient Database was used for this analysis. Depression was defined as International Classification of Diseases, 9th Revision, Clinical Modification codes 296.2-296.36, 300.4 or 311. Differences in hospital length of stay and mean cost per day by payer type were discerned via adjusted least square mean analysis (+/-S.E.). RESULTS: The adjusted mean hospital length of stay was significantly higher (P<.0001) for patients with a public payer (6.6+/-0.05 days) versus a private payer (5.3+/-0.05 days). Although statistically significant (P<.0001), the adjusted mean charge per day differed little by payer type (public, US$1316.39+/-9.82; private, US$1357.51+/-9.07). CONCLUSIONS: Further research is required to discern whether observed differences in hospital length of stay are the result of private payers enhancing patient care, thereby discharging patients in a more efficient manner, or the patients being discharged prematurely from the hospital due to constraints in reimbursement by private payers.


Subject(s)
Depression/diagnosis , Hospitalization , Insurance, Health, Reimbursement/classification , Length of Stay/economics , Adolescent , Child , Child, Preschool , Female , Humans , International Classification of Diseases , Length of Stay/statistics & numerical data , Male , Private Sector , Public Sector
10.
J Dent Educ ; 71(5): 592-4, 2007 May.
Article in English | MEDLINE | ID: mdl-17493967

ABSTRACT

Whether public or private dental insurance will provide benefits for caries management practices is a business decision. The foundation for this decision is multifactorial and continually changing as the values of the purchasers and health care consumers evolve. Understanding the dynamics involved in allocating finite health care resources will help those who advocate for caries management inform decision makers about the potential benefits of these strategies.


Subject(s)
Dental Caries/therapy , Insurance, Dental , Cost Savings , Decision Making , Dental Care/economics , Financial Management/economics , Health Policy , Health Resources/economics , Humans , Insurance Benefits/economics , Insurance, Dental/economics , Insurance, Health, Reimbursement/classification , Insurance, Health, Reimbursement/economics , Needs Assessment , Practice Patterns, Dentists'/economics , Risk Assessment
15.
J Health Econ ; 21(3): 451-74, 2002 May.
Article in English | MEDLINE | ID: mdl-12022268

ABSTRACT

In this paper, we estimate the returns associated with the provision of coronary artery bypass graft (CABG) surgery, by payer type (Medicare, HMO, etc.). Because reliable measures of prices and treatment costs are often unobserved, we seek to infer returns from hospital entry behavior. We estimate a model of patient flows for CABG patients that provides inputs for an entry model. We find that FFS provides a high return throughout the study period. Medicare, which had been generous in the early 1980s, now provides a return that is close to zero. Medicaid appears to reimburse less than average variable costs. HMOs essentially pay at average variable costs, though the return varies inversely with competition.


Subject(s)
Coronary Artery Bypass/economics , Coronary Artery Bypass/statistics & numerical data , Economics, Hospital/statistics & numerical data , Insurance, Health, Reimbursement/classification , California , Decision Making, Organizational , Fee-for-Service Plans/economics , Health Maintenance Organizations/economics , Health Services Research , Humans , Income/statistics & numerical data , Insurance, Health, Reimbursement/economics , Insurance, Hospitalization/economics , Marketing of Health Services/economics , Medicaid/economics , Medicare/economics , Models, Econometric , Product Line Management/economics , United States
16.
Public Health Rep ; 116(3): 219-25, 2001.
Article in English | MEDLINE | ID: mdl-12034911

ABSTRACT

OBJECTIVE: To assess adequacy of reimbursement for childhood vaccinations in two rural regions in Colorado, the authors measured medical practice costs of providing childhood vaccinations and compared them with reimbursement. METHODS: A "time-motion" method was used to measure labor costs of providing vaccinations in 13 private and public practices. Practices reported non-labor costs. The authors determined reimbursement by record review. RESULTS: The average vaccine delivery cost per dose (excluding vaccine cost) ranged from $4.69 for community health centers to $5.60 for private practices. Average reimbursement exceeded average delivery costs for all vaccines and contributed to overhead in private practices. Average reimbursement was less than total cost (vaccine-delivery costs + overhead) in private practices for most vaccines in one region with significant managed care penetration. Reimbursement to public providers was less than the average vaccine delivery costs. CONCLUSIONS: Current reimbursement may not be adequate to induce private practices to provide childhood vaccinations, particularly in areas with substantial managed care penetration.


Subject(s)
Child Health Services/economics , Community Health Centers/economics , Immunization Programs/economics , Insurance, Health, Reimbursement/statistics & numerical data , Private Practice/economics , Rural Health Services/economics , Child , Colorado , Cost Allocation , Health Maintenance Organizations/economics , Humans , Insurance, Health, Reimbursement/classification , Medicaid , Medical Assistance , Personnel Staffing and Scheduling/economics , State Health Plans/economics , Time and Motion Studies , United States
17.
Health Aff (Millwood) ; 19(2): 173-84, 2000.
Article in English | MEDLINE | ID: mdl-10718031

ABSTRACT

The health insurance market consists of three distinct segments--individual, small group, and large group--each governed by different economic and regulatory structures. A number of border-crossing techniques have arisen for avoiding the burdens of one segment and capitalizing on the benefits of others. Drawing from extensive qualitative research into the functioning of existing market structures, this paper describes these techniques and their purposes and effects. This road map helps to identify which reform proposals seek to produce true economic efficiencies and which have the potential to undermine previous reform objectives.


Subject(s)
Facility Regulation and Control/organization & administration , Insurance, Health, Reimbursement/classification , Insurance, Health, Reimbursement/economics , Marketing of Health Services/organization & administration , Colorado , Efficiency, Organizational , Florida , Health Services Research , Humans , Insurance, Health, Reimbursement/legislation & jurisprudence , Iowa , New York , North Carolina , Ohio , Organizational Objectives , Organizational Policy , Vermont
19.
Pediatrics ; 102(4 Pt 1): 996-8, 1998 Oct.
Article in English | MEDLINE | ID: mdl-9755276

ABSTRACT

In today's rapidly changing health care environment, it is crucial to understand the genesis and concepts of the Medicare Resource-based Relative Value Scale (RBRVS) physician fee schedule. Many third-party payers, including state Medicaid programs, Blue Cross-Blue Shield agencies, and managed care organizations are using variations of the Medicare RBRVS to determine physician reimbursement and capitation rates. Because the RBRVS fee schedule was originally created for Medicare only, pediatric-specific Current Procedural Terminology codes and pediatric practice expense issues were not included. The American Academy of Pediatrics agrees with the use of the Current Procedural Terminology codes and the RBRVS physician fee schedule and continues to work to rectify the inequities of the RBRVS system as they pertain to pediatrics.


Subject(s)
Pediatrics/classification , Relative Value Scales , Child , Fees, Medical , Humans , Insurance, Health, Reimbursement/classification , Pediatrics/economics , Professional Practice/economics , Terminology as Topic , United States
SELECTION OF CITATIONS
SEARCH DETAIL
...